CN Patent

CN110944670B — 调制激酶的化合物的制剂

Assigned to First Three Jsc · Expires 2023-03-10 · 3y expired

What this patent protects

提供了组合物，其包括具有以下结构的化合物I：或其药学上可接受的盐，和增溶剂；其制备方法；以及其使用方法。

USPTO Abstract

提供了组合物，其包括具有以下结构的化合物I：或其药学上可接受的盐，和增溶剂；其制备方法；以及其使用方法。

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN110944670B
Jurisdiction: CN
Classification: —
Expires: 2023-03-10
Drug substance claim: No
Drug product claim: No
Assignee: First Three Jsc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.